Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $113.34 USD
Change Today +4.85 / 4.47%
Volume 1.3M
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:48 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roy A. Whitfield

AgeTotal Calculated CompensationThis person is connected to 45 board members in 4 different organizations across 6 different industries.

See Board Relationships
61--

Background*

Mr. Roy A. Whitfield served as the Chief Executive Officer of Hexagen PLC. Mr. Whitfield has over 20 years of management and governance experience in the biotechnology industry. He co-founded Incyte Corp., (formerly, Incyte Genomics, Inc.) in 1991 and served as its Chairman of the Board from November 2001 to June 24, 2003, Chief Executive Officer from June 1993 to November 2001, President from June 1991 to January 1997 and Treasurer from April 1991 to October 1995. At ...

Read Full Background

Corporate Headquarters*

1801 Augustine Cut-Off
Wilmington, Delaware 19803

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

Director
2000-Present
Independent Director and Chairman of Nominating & Corporate Governance Committee
2006-Present
Executive Chairman
2007-Present
Director, Member of Compensation Committee and Member of Audit Committee

Education*

MBA
Stanford University
BS
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $113.40 USD +4.91

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
$1.4M
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.